Last checked at 8 Feb 2012 14:00
null
e-Therapeutics to present at the 14th Annual BIO CEO & Investor Conference
Oxford and Newcastle, UK, 8 February 2012 - Drug discovery and development company e-Therapeutics plc (AIM: ETX) announces that its CFO, Dr Daniel Elger, will present an overview of the Company's strategy, platform and clinical development programmes at the 14th Annual BIO CEO & Investor Conference in New York on Monday 13 February at 2.00 pm EST (1900 BST).
A webcast of the presentation will be available on e-Therapeutics' website at http://www.etherapeutics.co.uk
For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.
About e-Therapeutics
e-Therapeutics is an AIM-listed biotechnology company with a proprietary platform in network pharmacology, an innovative new approach to drug discovery based on advances in network science and chemical biology. The Company's discovery activity is focused in cancer and degenerative diseases of the nervous system and its development effort on four clinical candidates spanning cancer, psychiatric disorders and infectious diseases. e-Therapeutics is based at sites in Oxford and Newcastle, UK. For more information about the Company please visit www.etherapeutics.co.uk.
Contacts:
e-Therapeutics plcMalcolm Young / Daniel ElgerTel: +44 (0) 7909 915 068www.etherapeutics.co.uk
Panmure Gordon (UK) LimitedAndrew Burnett / Fred WalshTel: +44 (0) 20 7459 3600www.panmure.com
College HillMelanie Toyne Sewell / Jayne CrookTel: +44 (0) 20 7457 2020Email: e-therapeutics@collegehill.com
CommStrat Group (US)Ted AgneTel: (+1) 781 631 3117Email: edagne@comstratgroup.com
Copyright Business Wire 2012